187 related articles for article (PubMed ID: 21086164)
1. miR-373 negatively regulates methyl-CpG-binding domain protein 2 (MBD2) in hilar cholangiocarcinoma.
Chen Y; Luo J; Tian R; Sun H; Zou S
Dig Dis Sci; 2011 Jun; 56(6):1693-701. PubMed ID: 21086164
[TBL] [Abstract][Full Text] [Related]
2. Mutual regulation between microRNA-373 and methyl-CpG-binding domain protein 2 in hilar cholangiocarcinoma.
Chen YJ; Luo J; Yang GY; Yang K; Wen SQ; Zou SQ
World J Gastroenterol; 2012 Aug; 18(29):3849-61. PubMed ID: 22876037
[TBL] [Abstract][Full Text] [Related]
3. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
4. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
5. Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.
Pan ZX; Zhang XY; Chen SR; Li CZ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3645-3653. PubMed ID: 31114989
[TBL] [Abstract][Full Text] [Related]
6. Methylated DNA binding domain protein 2 (MBD2) coordinately silences gene expression through activation of the microRNA hsa-mir-496 promoter in breast cancer cell line.
Alvarado S; Wyglinski J; Suderman M; Andrews SA; Szyf M
PLoS One; 2013; 8(10):e74009. PubMed ID: 24204564
[TBL] [Abstract][Full Text] [Related]
7. Differential methylation of the micro-RNA 7b gene targets postnatal maturation of murine neuronal Mecp2 gene expression.
Chen Y; Shin BC; Thamotharan S; Devaskar SU
Dev Neurobiol; 2014 Apr; 74(4):407-425. PubMed ID: 24039126
[TBL] [Abstract][Full Text] [Related]
8. Methyl-CpG Binding Domain Protein 2 Inhibits the Malignant Characteristic of Lung Adenocarcinoma through the Epigenetic Modulation of 10 to 11 Translocation 1 and miR-200s.
Pei YF; Xu XN; Wang ZF; Wang FW; Wu WD; Geng JF; Liu XQ
Am J Pathol; 2019 May; 189(5):1065-1076. PubMed ID: 30735628
[TBL] [Abstract][Full Text] [Related]
9. Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.
Mian OY; Wang SZ; Zhu SZ; Gnanapragasam MN; Graham L; Bear HD; Ginder GD
Mol Cancer Res; 2011 Aug; 9(8):1152-62. PubMed ID: 21693597
[TBL] [Abstract][Full Text] [Related]
10. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
[TBL] [Abstract][Full Text] [Related]
11. Methyl-CpG binding domain protein 2 represses transcription from hypermethylated pi-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells.
Bakker J; Lin X; Nelson WG
J Biol Chem; 2002 Jun; 277(25):22573-80. PubMed ID: 11960994
[TBL] [Abstract][Full Text] [Related]
12. miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma.
Duan W; Huang J; Wasti B; Chen Z; Yuan Y; He Y; Li D; Jia J; Liu S; Liu Y; Ma L; Zeng Q; Zhu L; Li J; Zhang X; Xiang X
Clin Exp Med; 2023 Oct; 23(6):2839-2854. PubMed ID: 36961677
[TBL] [Abstract][Full Text] [Related]
13. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
[TBL] [Abstract][Full Text] [Related]
14. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
15. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
Auriol E; Billard LM; Magdinier F; Dante R
Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
[TBL] [Abstract][Full Text] [Related]
18. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
19. A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene.
Chatagnon A; Ballestar E; Esteller M; Dante R
PLoS One; 2010 Mar; 5(3):e9665. PubMed ID: 20300195
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
